Indication
Radiation-induced mucositis
Radiation-induced mucositis is an acute, debilitating inflammatory condition of the mucosal lining that occurs as a normal-tissue complication of ionizing radiation exposure, most frequently observed in patients receiving radiotherapy for head and neck cancers. Read more about Radiation-induced mucositis
5 drugs 5 manufacturers
Drugs that treat it
Common Radiation-induced mucositis therapies.
GELCLAIR (potassium sorbate/hydroxyethylcellulose/povidone/hyaluronic)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonRadiation-induced mucositis is an acute, debilitating inflammatory condition of the mucosal lining that occurs as a normal-tissue complication of ionizing radiation exposure, most frequently observed in patients receiving radiotherapy for head and neck cancers.
It is pathophysiologically driven by radiation-triggered DNA damage, reactive oxygen species generation, and pro-inflammatory cytokine signaling, which impair basal epithelial renewal and cause progressive mucosal atrophy.
Clinically, the condition manifests as intense erythema, edema, and mucosal ulcerations, typically leading to severe pain, dysphagia, malnutrition, and an increased vulnerability to secondary local or systemic infections.
- nih.gov
Radiation-induced mucositis is an acute, debilitating inflammatory condition of the mucosal lining that occurs as a normal-tissue complication of ionizing radiation exposure, most frequently observed in patients receiving radiotherapy for head and neck cancers It is pathophysiologically driven by radiation-triggered DNA damage, reactive oxygen species generation, and pro-inflammatory cytokine signaling, which impair basal epithelial renewal and cause progressive mucosal atrophy Clinically, the c...
- nih.gov
Radiation-induced mucositis is an acute, debilitating inflammatory condition of the mucosal lining that occurs as a normal-tissue complication of ionizing radiation exposure, most frequently observed in patients receiving radiotherapy for head and neck cancers
- nih.gov
It is pathophysiologically driven by radiation-triggered DNA damage, reactive oxygen species generation, and pro-inflammatory cytokine signaling, which impair basal epithelial renewal and cause progressive mucosal atrophy
- nih.gov
Clinically, the condition manifests as intense erythema, edema, and mucosal ulcerations, typically leading to severe pain, dysphagia, malnutrition, and an increased vulnerability to secondary local or systemic infections
- nih.gov
Clinically, the condition manifests as intense erythema, edema, and mucosal ulcerations, typically leading to severe pain, dysphagia, malnutrition, and an increased vulnerability to secondary local or systemic infections
Personalize your experience
Follow Radiation-induced mucositis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.